FDA Panelists to Assess Opioid/Food Interactions http://www.medpagetoday.com/Neurology/GeneralNeurology/53477?xid=nl_mpt_DHE_2015-09-10&eun=g578717d0r If this follows the same path as to when Purdue make Oxycontin abuse-deterrent… the FDA revoked the NDA (New Drug Application) which meant that a LESS EXPENSIVE GENERIC could no longer be produced… This abuse-deterrent IR form of Oxycodone could mean that the LESS EXPENSIVE GENERIC could be […]
Filed under: General Problems | Leave a Comment »

















